Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium

  • Israel M. Barbash
    From the Neufeld Cardiac Research Institute (I.M.B., P.C., J.B., M.S.F., S.E., A.T., L.M., J.L.) and Danek Gertner Institute of Human Genetics (E.G.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Molecular Cell Biology (D.Z.), Weizmann Institute of Science, Rehovot, Israel; Institute for Genetic Medicine (L.H.K., R.A.K.), Department of Biochemistry & Molecular Biology, Los Angeles, Calif; Department of Medicine (L.H.K.), Keck School of Medicine of the University of Southern...
  • Pierre Chouraqui
    From the Neufeld Cardiac Research Institute (I.M.B., P.C., J.B., M.S.F., S.E., A.T., L.M., J.L.) and Danek Gertner Institute of Human Genetics (E.G.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Molecular Cell Biology (D.Z.), Weizmann Institute of Science, Rehovot, Israel; Institute for Genetic Medicine (L.H.K., R.A.K.), Department of Biochemistry & Molecular Biology, Los Angeles, Calif; Department of Medicine (L.H.K.), Keck School of Medicine of the University of Southern...
  • Jack Baron
    From the Neufeld Cardiac Research Institute (I.M.B., P.C., J.B., M.S.F., S.E., A.T., L.M., J.L.) and Danek Gertner Institute of Human Genetics (E.G.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Molecular Cell Biology (D.Z.), Weizmann Institute of Science, Rehovot, Israel; Institute for Genetic Medicine (L.H.K., R.A.K.), Department of Biochemistry & Molecular Biology, Los Angeles, Calif; Department of Medicine (L.H.K.), Keck School of Medicine of the University of Southern...
  • Micha S. Feinberg
    From the Neufeld Cardiac Research Institute (I.M.B., P.C., J.B., M.S.F., S.E., A.T., L.M., J.L.) and Danek Gertner Institute of Human Genetics (E.G.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Molecular Cell Biology (D.Z.), Weizmann Institute of Science, Rehovot, Israel; Institute for Genetic Medicine (L.H.K., R.A.K.), Department of Biochemistry & Molecular Biology, Los Angeles, Calif; Department of Medicine (L.H.K.), Keck School of Medicine of the University of Southern...
  • Sharon Etzion
    From the Neufeld Cardiac Research Institute (I.M.B., P.C., J.B., M.S.F., S.E., A.T., L.M., J.L.) and Danek Gertner Institute of Human Genetics (E.G.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Molecular Cell Biology (D.Z.), Weizmann Institute of Science, Rehovot, Israel; Institute for Genetic Medicine (L.H.K., R.A.K.), Department of Biochemistry & Molecular Biology, Los Angeles, Calif; Department of Medicine (L.H.K.), Keck School of Medicine of the University of Southern...
  • Ariel Tessone
    From the Neufeld Cardiac Research Institute (I.M.B., P.C., J.B., M.S.F., S.E., A.T., L.M., J.L.) and Danek Gertner Institute of Human Genetics (E.G.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Molecular Cell Biology (D.Z.), Weizmann Institute of Science, Rehovot, Israel; Institute for Genetic Medicine (L.H.K., R.A.K.), Department of Biochemistry & Molecular Biology, Los Angeles, Calif; Department of Medicine (L.H.K.), Keck School of Medicine of the University of Southern...
  • Liron Miller
    From the Neufeld Cardiac Research Institute (I.M.B., P.C., J.B., M.S.F., S.E., A.T., L.M., J.L.) and Danek Gertner Institute of Human Genetics (E.G.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Molecular Cell Biology (D.Z.), Weizmann Institute of Science, Rehovot, Israel; Institute for Genetic Medicine (L.H.K., R.A.K.), Department of Biochemistry & Molecular Biology, Los Angeles, Calif; Department of Medicine (L.H.K.), Keck School of Medicine of the University of Southern...
  • Esther Guetta
    From the Neufeld Cardiac Research Institute (I.M.B., P.C., J.B., M.S.F., S.E., A.T., L.M., J.L.) and Danek Gertner Institute of Human Genetics (E.G.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Molecular Cell Biology (D.Z.), Weizmann Institute of Science, Rehovot, Israel; Institute for Genetic Medicine (L.H.K., R.A.K.), Department of Biochemistry & Molecular Biology, Los Angeles, Calif; Department of Medicine (L.H.K.), Keck School of Medicine of the University of Southern...
  • Dov Zipori
    From the Neufeld Cardiac Research Institute (I.M.B., P.C., J.B., M.S.F., S.E., A.T., L.M., J.L.) and Danek Gertner Institute of Human Genetics (E.G.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Molecular Cell Biology (D.Z.), Weizmann Institute of Science, Rehovot, Israel; Institute for Genetic Medicine (L.H.K., R.A.K.), Department of Biochemistry & Molecular Biology, Los Angeles, Calif; Department of Medicine (L.H.K.), Keck School of Medicine of the University of Southern...
  • Laurence H. Kedes
    From the Neufeld Cardiac Research Institute (I.M.B., P.C., J.B., M.S.F., S.E., A.T., L.M., J.L.) and Danek Gertner Institute of Human Genetics (E.G.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Molecular Cell Biology (D.Z.), Weizmann Institute of Science, Rehovot, Israel; Institute for Genetic Medicine (L.H.K., R.A.K.), Department of Biochemistry & Molecular Biology, Los Angeles, Calif; Department of Medicine (L.H.K.), Keck School of Medicine of the University of Southern...
  • Robert A. Kloner
    From the Neufeld Cardiac Research Institute (I.M.B., P.C., J.B., M.S.F., S.E., A.T., L.M., J.L.) and Danek Gertner Institute of Human Genetics (E.G.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Molecular Cell Biology (D.Z.), Weizmann Institute of Science, Rehovot, Israel; Institute for Genetic Medicine (L.H.K., R.A.K.), Department of Biochemistry & Molecular Biology, Los Angeles, Calif; Department of Medicine (L.H.K.), Keck School of Medicine of the University of Southern...
  • Jonathan Leor
    From the Neufeld Cardiac Research Institute (I.M.B., P.C., J.B., M.S.F., S.E., A.T., L.M., J.L.) and Danek Gertner Institute of Human Genetics (E.G.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Molecular Cell Biology (D.Z.), Weizmann Institute of Science, Rehovot, Israel; Institute for Genetic Medicine (L.H.K., R.A.K.), Department of Biochemistry & Molecular Biology, Los Angeles, Calif; Department of Medicine (L.H.K.), Keck School of Medicine of the University of Southern...

書誌事項

タイトル別名
  • Feasibility, Cell Migration, and Body Distribution
公開日
2003-08-19
DOI
  • 10.1161/01.cir.0000084828.50310.6a
公開者
Ovid Technologies (Wolters Kluwer Health)

この論文をさがす

説明

<jats:p> <jats:bold> <jats:italic>Background—</jats:italic> </jats:bold> Systemic delivery of bone marrow–derived mesenchymal stem cells (BM-MSCs) is an attractive approach for myocardial repair. We aimed to test this strategy in a rat model after myocardial infarction (MI). </jats:p> <jats:p> <jats:bold> <jats:italic>Methods and Results—</jats:italic> </jats:bold> BM-MSCs were obtained from rat bone marrow, expanded in vitro to a purity of >50%, and labeled with <jats:sup>99m</jats:sup> Tc exametazime, fluorescent dye, <jats:italic>LacZ</jats:italic> marker gene, or bromodeoxyuridine. Rats were subjected to MI by transient coronary artery occlusion or to sham MI. <jats:sup>99m</jats:sup> Tc-labeled cells (4×10 <jats:sup>6</jats:sup> ) were transfused into the left ventricular cavity of MI rats either at 2 or 10 to 14 days after MI and were compared with sham-MI rats or MI rats treated with intravenous infusion. Gamma camera imaging and isolated organ counting 4 hours after intravenous infusion revealed uptake of the <jats:sup>99m</jats:sup> Tc-labeled cells mainly in the lungs, with significantly smaller amounts in the liver, heart, and spleen. Delivery by left ventricular cavity infusion resulted in drastically lower lung uptake, better uptake in the heart, and specifically higher uptake in infarcted compared with sham-MI hearts. Histological examination at 1 week after infusion identified labeled cells either in the infarcted or border zone but not in remote viable myocardium or sham-MI hearts. Labeled cells were also identified in the lung, liver, spleen, and bone marrow. </jats:p> <jats:p> <jats:bold> <jats:italic>Conclusions—</jats:italic> </jats:bold> Systemic intravenous delivery of BM-MSCs to rats after MI, although feasible, is limited by entrapment of the donor cells in the lungs. Direct left ventricular cavity infusion enhances migration and colonization of the cells preferentially to the ischemic myocardium. </jats:p>

収録刊行物

  • Circulation

    Circulation 108 (7), 863-868, 2003-08-19

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (20)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ